Gregory Olsovsky, MD
Clinical Cardiac Electrophysiology · Temple, TXNPI 1215998091
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,211 of the $2,786 with a category attached, or 79.4%. 12 manufacturers reported payments, led by Abbott at 49.8% of the total. 2025 is the largest year on record at $914, more than ten times the $52 reported in 2019. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in TX, where the typical reported total is $27,892.
Across 138 payments — averaging $20.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$1K
- Biosense Webster, Inc.$508
- Stereotaxis Inc$146
- Medtronic$144
- E.r. Squibb & Sons, L.L.C.$142
- Cardiofocus, Inc.$131
- plus $326 from 6 others
Across 14 payments — averaging $1108.37 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$16K
What the payments were for
- Travel & lodging$57521%
- Food & beverage$2,21179%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 29 | $1,389 |
| Biosense Webster, Inc. | 76 | $508 |
| Stereotaxis Inc | 5 | $146 |
| Medtronic | 2 | $144 |
| E.r. Squibb & Sons, L.L.C. | 8 | $142 |
| Cardiofocus, Inc. | 1 | $131 |
| Boston Scientific | 6 | $125 |
| Cardiva Medical, Inc. | 5 | $84 |
| Pfizer | 3 | $68 |
| Atricure, Inc. | 1 | $24 |
| Johnson & Johnson | 1 | $16 |
| Acutus Medical, Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AVEIR$557
- Micra$131
- Confirm Rx$108
How this compares
$2,786 in reported general payments places this provider in the 5th percentile of 233 clinical cardiac electrophysiology providers in Texas.
See all clinical cardiac electrophysiology providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 558 | $588,715 |
| MultaqDronedarone Hcl | 109 | $153,581 |
| XareltoRivaroxaban | 75 | $89,273 |
| Flecainide Acetate | 298 | $22,144 |
| Metoprolol Succinate | 292 | $7,316 |
| Dofetilide | 21 | $6,092 |
| Amiodarone Hcl | 139 | $4,329 |
| SotalolSotalol Hcl | 85 | $4,030 |
| Propafenone Hcl ErPropafenone Hcl | 17 | $3,742 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 98 | $3,240 |
| Mexiletine Hcl | 12 | $1,471 |
| Metoprolol Tartrate | 99 | $1,309 |
| Digoxin | 45 | $1,236 |
| Losartan Potassium | 62 | $1,168 |
| Lisinopril | 73 | $1,141 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $68 | $588,715558 claims |
| Johnson & JohnsonXarelto | $16 | $89,27375 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 5th percentile of 233 clinical cardiac electrophysiology providers in Texas.
Other clinical cardiac electrophysiology in Temple
- Ethan FryTemple$67K
- Michael DelaughterBedford$1.6M
- Andrea NataleAustin$1.3M
- Jason ZagrodzkyAustin$961K
- Amin Al-AhmadAustin$771K
- Dale YooMcKinney$585K
- Rodney HortonAustin$553K
- Jose Cuellar SilvaWebster$502K
- Miguel ValderrabanoHouston$461K
- Theodore TakataFort Worth$396K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.